![James DeTore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James DeTore
Finanzdirektor/CFO bei
CG ONCOLOGY, INC.
Profil
James M.
DeTore is currently Chief Financial Officer at CG Oncology, Inc. since 2026.
Former positions include Chief Financial Officer at Neurogastrx, Inc. from 2021 to 2025; Chief Financial Officer & Treasurer at Proteostasis Therapeutics, Inc. from 2016 to 2017; Chief Financial Officer & Treasurer at Genetix Biotherapeutics, Inc. from 2014 to 2016; Vice President-Finance & Administration at Ironwood Pharmaceuticals, Inc. from 2012 to 2014; Controller at Microbia, Inc. from 2003 to 2006; Principal at Genzyme Corp.; and Principal at Data General Corp.
Education includes undergraduate and MBAistration degrees from Northeastern University.
Aktive Positionen von James DeTore
| Unternehmen | Position | Beginn |
|---|---|---|
| CG ONCOLOGY, INC. | Finanzdirektor/CFO | 17.11.2025 |
Ehemalige bekannte Positionen von James DeTore
| Unternehmen | Position | Ende |
|---|---|---|
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Finanzdirektor/CFO | 01.06.2025 |
| PROTEOSTASIS THERAPEUTICS, INC. | Finanzdirektor/CFO | 10.02.2017 |
| GENETIX BIOTHERAPEUTICS, INC. | Finanzdirektor/CFO | 01.03.2016 |
| IRONWOOD PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 17.06.2011 |
Microbia, Inc.
 Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Comptroller/Controller/Auditor | 01.01.2006 |
Ausbildung von James DeTore
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
52
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Data General Corp.
 Data General Corp. Computer PeripheralsElectronic Technology Designs and makes open computer systems including servers and mass storage products | Electronic Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Develops microbial manufacturing technologies | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops transformative therapies for gastrointestinal disorders | Health Technology |
Wählen Sie MarketScreener 
